2024-03-31
0000200406
jnj:CARVYKTIMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:CARVYKTIMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:DARZALEXMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:DARZALEXMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:DARZALEXMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:DARZALEXMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:DARZALEXMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:DARZALEXMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:ERLEADAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:ERLEADAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:ERLEADAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:ERLEADAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:ERLEADAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:ERLEADAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:IMBRUVICAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:IMBRUVICAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:IMBRUVICAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:IMBRUVICAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:IMBRUVICAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:IMBRUVICAMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:RYBREVANTLAZCLUZEMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
country:US
jnj:RYBREVANTLAZCLUZEMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
us-gaap:NonUsMember
jnj:RYBREVANTLAZCLUZEMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
us-gaap:NonUsMember
jnj:RYBREVANTLAZCLUZEMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
jnj:RYBREVANTLAZCLUZEMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-12-30
2025-03-30
0000200406
jnj:RYBREVANTLAZCLUZEMember
jnj:InnovativeMedicineMember
jnj:OncologyMember
2024-01-01
2024-03-31
0000200406
country:US
jnj:TALVEYMember
jnj:InnovativeMedicineMember
jnj:OncologyMember